StonvexLoading…
StonvexStonvexStonvexCore line items from FNF's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.10B | $1.92B | $1.86B | $2.23B |
Operating Income | $1.40B | $1.74B | $693.00M | $1.73B |
Net Income | $602.00M | $1.27B | $517.00M | $1.29B |
EPS (Diluted) | $2.21 | $4.65 | $1.91 | $4.67 |
Total Assets | $109.01B | $95.26B | $80.61B | $65.14B |
Total Liabilities | $100.04B | $86.73B | $73.15B | $58.57B |
Cash & Equivalents | $2.64B | $3.48B | $2.77B | $2.29B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 271.00M | 275.00M | 273.00M | 272.31M |